登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603717 证券简称：天域生物 公告编号：2025-106 天域生物科技股份有限公司关于 变更保荐机构后重新签订募集资金 三方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 天域生物科技股份有限公司（以下简称"公司"）于2025年10月25日披露了《关于变更保荐机构及保荐代 表人的公告》（公告编号：2025-099），公司因聘请国海证券股份有限公司（以下简称"国海证券"）担 任公司2025年度向特定对象发行A股股票事项的保荐机构，原保荐机构中德证券有限责任公司尚未完成 的持续督导工作由国海证券承接。为规范募集资金管理，保护投资者利益，根据《上市公司募集资金监 管规则》《上海证券交易所股票上市规则》《上海证券交易所上市公司自律监管指引第1号一一规范运 作》等有关法律、法规和规范性文件的规定，公司于近日与国海证券、南洋商业银行（中国）有限公司 上海分行重新签订了《募集资金专户存储三方监管协议》。现将有关情况公告如下： 一、募集资金基本情况 经中国证券监督 ...

Group 1 - The company held its 22nd meeting of the 6th Board of Directors on November 20, 2025, via telecommunication, with all 8 directors present, meeting the legal quorum requirements [2][3][6] - The Board approved the proposal to conclude the fundraising project for issuing convertible bonds and to permanently supplement the remaining funds of 223.2049 million yuan into working capital for daily operations and business development [3][4][39] - The proposal to convene the second extraordinary general meeting of shareholders in 2025 was also approved, scheduled for December 10, 2025 [9][10][11] Group 2 - The company plans to transfer 90% of its wholly-owned subsidiary, Suzhou Jinlaike Precision Machinery Co., Ltd., to Suzhou Chuangyuan Resource Recycling Co., Ltd., with an intended total equity value of 235 million yuan [44][46] - This transaction does not constitute a related party transaction or a major asset restructuring, and the signed letter of intent is preliminary, subject to further due diligence and negotiations [45][46][66] - The decision to sell the subsidiary aims to optimize the company's asset structure and resource allocation, enhancing operational efficiency and reducing management costs [65]

Fundraising Overview - The company raised a total of RMB 1,759,999,998.24 through the issuance of 444,444,444 shares at a price of RMB 3.96 per share, with a net amount of RMB 1,727,912,422.10 after deducting issuance costs [1] Fund Management and Storage - The company established a fundraising management system to ensure effective use of raised funds, which are stored in a dedicated account [2] - A tripartite supervision agreement was signed with the sponsor and the bank to oversee the use of the funds [2] Changes in Fund Account - On July 3, 2023, the company approved a proposal to change the dedicated fundraising account from Industrial Bank to Bank of China [3] - A new tripartite supervision agreement was signed with the new bank to ensure compliance [3] Account Closure - The fundraising account was closed after the funds were fully utilized, and the corresponding supervision agreement was terminated [3][4]

上海雅仕投资发展股份有限公司 第四届董事会第十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 二、董事会会议审议情况 本次董事会会议审议并通过了以下议案： (一)审议通过《关于增加募投项目实施主体并使用部分募集资金向新增实施主体提供借款以实施募投项 目议案》 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603329 证券简称：上海雅仕 公告编号：2025-074 一、董事会会议召开情况 上海雅仕投资发展股份有限公司（以下简称"公司"）第四届董事会第十三次会议于2025年11月19日在公 司会议室以现场结合通讯表决方式召开，会议通知及相关资料已于2025年11月14日以电子邮件方式发 出。本次会议应出席会议的董事9名，实际出席会议的董事9名，其中现场参会董事4名，以通讯表决方 式参会董事5名，部分高级管理人员列席会议，本次会议由董事长刘忠义先生主持。会议参与表决人数 及召集、召开程序符合《公司法》和《公司章程》的有关规定，所作决议合法有效。 同意公司新增全资子公司湖北雅仕实业控股有限公司作为募投 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603329 证券简称：上海雅仕 公告编号：2025-076 上海雅仕投资发展股份有限公司 关于使用募集资金置换已支付发行 费用的自筹资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 上海雅仕投资发展股份有限公司（以下简称"公司""上海雅仕"）于2025年11月19日召开第四届董事会第 十三次会议，审议通过了《关于使用募集资金置换已支付发行费用的自筹资金的议案》，同意公司使用 募集资金置换已支付发行费用的自筹资金，置换金额为人民币752,830.19元（不含税），本次募集资金 置换时间距募集资金到账日未超过6个月，符合相关法律法规的规定。现将有关情况公告如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意上海雅仕投资发展股份有限公司向特定对象发行股票注册的批 复》（证监许可〔2025〕1825号）同意，公司本次向特定对象发行人民币普通股（A股）43,668,122 股，发行价格6.87元/股，募集资金总额为299,999,998.14元，扣除不含 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 ■ 盛美半导体设备（上海）股份有限公司 关于使用自有资金方式支付募投项目所需资金 并以募集资金等额置换的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 盛美半导体设备（上海）股份有限公司（以下简称"公司"、"盛美上海"）于2025年11月17日召开第三届 董事会第一次会议，审议通过了《关于使用自有资金方式支付募投项目所需资金并以募集资金等额置换 的议案》。为提升公司运营管理效率，同意公司在募集资金投资项目（以下简称"募投项目"）实施期间 使用自有资金方式支付募投项目所需部分资金，后续以募集资金等额置换，从募集资金专户划转资金至 公司非募集资金账户，该部分置换资金视同募投项目使用资金。保荐机构国泰海通证券股份有限公司 （以下简称"保荐机构"）对本事项出具了明确的核查意见，现将具体情况公告如下： 一、募集资金的基本情况 根据中国证券监督管理委员会核发的《关于同意盛美半导体设备（上海）股份有限公司向特定对象发行 股票注册的批复》（证监许可[2025]1338号），公司于20 ...

Core Points - The company held its 12th meeting of the 10th Board of Directors on November 18, 2025, where several key resolutions were passed [1][2][3][4]. Group 1: Board Resolutions - The company approved the nomination of Hua Guanglin as a candidate for a non-independent director, pending shareholder approval [2][5][87]. - The company accepted the resignation of Zhao Shukun as General Manager due to work adjustments and appointed Hua Guanglin as the new General Manager [6][84]. - The company resolved to amend its Articles of Association to align with new legal requirements and improve governance [9][37]. - The company decided to revise the rules for shareholder meetings to clarify responsibilities and ensure legal compliance [12][37]. - The company approved the revision of the rules for board meetings to enhance decision-making efficiency [15][37]. - The company resolved to abolish the Supervisory Board, transferring its responsibilities to the Audit and Risk Management Committee [18][37]. - The company agreed to use 120 million yuan of idle raised funds temporarily to supplement working capital, with a usage period not exceeding six months [21][67][76]. - The company scheduled its second extraordinary general meeting for 2025 on December 4, 2025 [24][41]. Group 2: Meeting Details - The board meeting was conducted in compliance with the Company Law and the company's Articles of Association, with all members present [1][4]. - The resolutions passed during the meeting will be submitted for approval at the upcoming shareholders' meeting [5][11][14][20]. Group 3: Management Changes - Hua Guanglin, the newly appointed General Manager, has a strong background in engineering and management, having held various positions within the company [26][86][89].

Core Points - Baichuan Co., Ltd. announced the approval of a proposal to permanently supplement working capital with surplus funds from a completed project [2] - The project, which involves the production of 30,000 tons of graphite anode materials, has reached its intended usable state and has a total investment of 1.42 billion yuan [2] - The surplus funds amount to 80.35 million yuan, representing 8.35% of the net raised funds from a convertible bond issuance [2] Fundraising and Financial Details - The surplus funds originated from the company's 2022 public issuance of convertible bonds, which raised a net amount of 962 million yuan after deducting issuance costs [2] - The project was completed by November 14, 2025, and the actual investment from the raised funds was 885 million yuan, with additional interest income contributing to the surplus [2][3] - The company plans to use the surplus funds entirely for working capital, while future payments for contracts and warranties will be covered by its own funds [3] Reasons for Surplus Funds - The surplus is attributed to strict cost control during project implementation, ensuring efficient investment while maintaining quality and progress [3] - The company engaged in compliant cash management of idle funds, generating stable investment returns and bank interest [3] - Delayed payment schedules for certain contract balances and warranty funds also contributed to the surplus [3]

证券代码：688400 证券简称：凌云光 公告编号：2025-084 公司于2022年8月5日、2022年8月23日分别召开了第一届董事会第十六次会议、第一届监事会第十三次 会议和2022年第一次临时股东大会，审议通过了《关于使用部分超募资金永久补充流动资金及剩余超募 资金用途的议案》《关于使用超额配售募集资金对部分募投项目增加投资的议案》《关于科技与发展储 备资金的未来具体项目规划的议案》，同意公司将首次公开发行股票超额配售募集资金全部用于向《凌 云光技术股份有限公司首次公开发行股票并在科创板上市招股说明书》中披露的募投项目"科技与发展 储备资金"增加投资，并对"科技与发展储备资金"的使用做了进一步细化，同时公司将使用补充流动资 金后剩余的超募资金（不含超额配售募集资金）用于"基于视觉+AI的虚拟现实融合内容制作中心"项 目。 2023年4月24日，公司召开第一届董事会第二十三次会议和第一届监事会第十九次会议，2023年5月18日 召开2022年年度股东大会，审议通过了《关于调整部分募投项目拟投入募集资金金额及使用暂时闲置募 集资金进行现金管理的议案》，同意调整募投项目"基于视觉+AI的虚拟现实融合内容制作 ...

证券代码：600596 证券简称：新安股份 公告编号：2025-062号 浙江新安化工集团股份有限公司 关于公司开立募集资金专项账户并签订募集资金专户存储 四方监管协议的公告 1.甲方已在乙方开设募集资金专项账户（以下简称"专户"），账户为3个月可转让大额存单。该专户仅 用于甲方二浙江开化合成材料有限公司搬迁入园提升项目部分募集资金的现金管理，不得用作其他用 途， 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意浙江新安化工集团股份有限公司向特定对象发行股票注册的批 复》（证监许可〔2023〕1342号），公司采用网下向配售对象询价配售方式，向特定对象发行人民币普 通股203,850,509股，发行价为每股人民币8.83元，共计募集资金1,799,999,994.47元，扣除承销和保荐费 用16,037,735.81元后的募集资金为1,783,962,258.66元，已于2023年11月30日汇入公司募集资金监管账 户。另减除审计及验资费用、律师费用、股权登记费等 ...